SEARCH

SEARCH BY CITATION

References

  • Anton R, Kordower JH, Maidment NT, Manaster JB, Kane DJ, Rabizadeh S et al. (1994) Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp. Neurol. 127, 200218.
  • Anton R, Kordower JH, Kane DJ, Markham CH, Bredesen DE (1995) Neural transplantation of cells expressing the anti-apoptotic gene bcl-2. Cell. Transpl. 4, 4954.
  • Auerbach JM, Eiden MV, McKay RDG (2000) Transplanted CNS stem cells form functional synapses in vivo. Eur. J. Neurosci. 12, 16961704.
  • Backlund EO, Granberg PO, Hamberger B, Knutsson E, Martensson A, Sedvall G et al. (1985) Transplantation of adrenal medullary tissue to striatum in parkinsonism: first clinical trials. J. Neurosurg. 2, 169173.
  • Bäckman C, Perlmann T, Wallen A, Hoffer BJ, Morales M (1999) A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain. Res. 851, 125132.
  • Björklund A (1992) Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr. Opin. Neurobiol. 2, 683689.
  • Björklund A, Lindvall O (2000) Cell replacement therapies for central nervous system disorders. Nature Neurosci. 3, 537544.
  • Brundin P, Wictorin K (1993) Neural transplantation in rat models of Parkinson's and Huntington's diseases. Sem. Neurosci. 5, 413421.
  • Buc-Caron MH (1995) Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro. Neurobiol. Dis. 2, 3747.
  • Cattaneo E, Conti L (1998) Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J. Neurosci. Res. 53, 223234.
  • Cazorla P, Smidt MP, O'Malley KL, Burbach JPH (2000) A response element for the homeodomain transcription factor Ptx3 in the tyrosine hydroxylase gene promoter. J. Neurochem. 74, 18291837.
  • Deacon T, Schumacher J, Dinsmore J, Thomas C, Palmer P, Kott S et al. (1997) Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nature Med. 3, 350353.
  • Dunnett SB, Björklund A (1999) Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399 (Suppl.), 3239.
  • Eells JB, Rives JE, Yeung SK, Nikodem VM (2001) In vitro regulated expression of tyrosine hydroxylase in ventral midbrain neurons from Nurr1-null mouse pups. J. Neurosci. Res. 64, 322330.
  • Frederiksen K, Jat PS, Valtz N, Levy D, McKay RDG (1988) Immortalization of precursor cells from the mammalian CNS. Neuron 1, 439448.
  • Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710719.
  • Gordon CJ (1990) Thermal biology of the laboaratory rat. Physiol. Behav. 47, 963991.
  • Haque NSK, LeBlanc CJ, Isacson O (1997) Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons. Cell Transpl. 6, 239248.
  • Herman JP, Abrous ND (1994) Dopaminergic neural grafts after fifteen years: results and perspectives. Prog. Neurobiol. 44, 135.
  • Kathmann EC, Naylor S, Lipsky JJ (2000) Rat liver constitutive and phenobarbital-inducible cytosolic aldehyde dehydrogenases are highly homologous proteins that function as distinct isozymes. Biochemistry 39, 1117011176.
  • Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227, 680685.
  • Le W, Conneely OM, Jankovic J, Appel SH (1999) Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J. Neurochem. 73, 22182221.
  • Lendahl U, Zimmermann LB, McKay RDG (1990) CNS stem cells express an new class of intermediate filament protein. Cell 60, 58595.
  • Martinez-Serrano A, Björklund A (1997) Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci. 20, 530538.
  • McCaffery P, Dräger UC (1994) High levels of retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc. Natl. Acad. Sci. USA 91, 77727776.
  • Olanow CW, Kordower JH, Freeman TB (1996) Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102109.
  • Olson L, Strömberg I, Ebendal T, Seiker A, Hoffer B (1991) Grafting strategies in Parkinson's disease: the chromaffin alternative. Rest. Neurol. 4, 314.
  • Perrone-Capano C, Di Porzio U (2000) Genetic and epigenetic control of midbrain dopaminergic neuron development. Int. J. Dev. Biol. 44, 679687.
  • Piccini P, Brooks DJ, Björklund A, Gunn RN, Grasby PM, Rimoldi O et al. (1999) Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nature Neurosci. 2, 11371140.
  • Redies C, Lendahl U, McKay RDG (1991) Differentiation and heterogeneity in T-antigen immortalized precursor cell lines from mouse cerebellum. J. Neurosci. Res. 30, 601615.
  • Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F et al. (1998) Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA 95, 40134018.
  • Snyder EY (1994) Grafting immortalized neurons to the CNS. Curr. Opin. Neurobiol. 4, 742751.
  • Veizovic T, Beech JS, Sroemer RP, Watson WP, Hodges H (2001) Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 32, 10121019.
  • Wagner J, Akerud P, Castro DS, Holm PC, Canals JM, Snyder EY et al. (1999) Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nature Biotechnol. 17, 653659.
  • Wallen A, Zetterström RH, Solomin L, Arvidsson M, Olson L, Perlmann T (1999) Fate of mesencephalic AHD2-expressing dopaminergic progenitor cells in NURR1 mutant mice. Exp. Cell Res. 253, 737746.
  • Winkler C, Fricker RA, Gates MA, Olsson M, Hammang JP, Carpenter MK et al. (1998) Incorporation and glial differentiation of mouse EGF-responsive neural progenitor cells after transplantation into the embryonic rat brain. Mol. Cell. Neurosci. 11, 99116.
  • Yandava BD, Billinghurst LL, Snyder EY (1999) ‘Global’ cell replacement is feasible via neural stem cell transplantation: evidence from the dismyelinated shiverer mouse brain. Proc. Nat. Acad. Sci. USA 96, 70297034.
  • Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T (1997) Dopamin neuron agenesis in Nurr1-deficient mice. Science 276, 248250.
  • Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH et al. (1993) Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90, 45334537.